Megakaryocyte morphology and its impact in predicting response to steroid in immune thrombocytopenia

Platelets

Volumn 25, Issue 7, 2014, Pages 526-531

  Tripathi, Anil Kumar ^a   Mishra, Sanjay ^a   Kumar, Ashutosh ^a   Yadav, Deependra ^a   Shukla, Ayush ^a   Yadav, Yogendra ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Immune thrombocytopenia; Megakaryocytic morphology; Response; Steroids; TPO RA (eltrombopag)

Indexed keywords

ELTROMBOPAG; STEROID;

ADULT; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BONE MARROW BIOPSY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MEGAKARYOCYTE; PRIMARY IMMUNE THROMBOCYTOPENIA; PROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTE STRUCTURE; THROMBOCYTE VOLUME; TREATMENT OUTCOME; BLOOD; PATHOLOGY; PREDICTIVE VALUE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOCYTE;

ADULT; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MEGAKARYOCYTES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; STEROIDS;

EID: 84912044981     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2013.845875     Document Type: Article

References (15)

1. Rodeghiero F, Roberto S, Terry GM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009;113: 2386-2393
2. Sakakura M, Wada H, Tawara I, et al. Reduced CD4 CD25-T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res 2007;120:187-193
3. Yu J, Heck S, Patel V, et al. Defective circulating CD 25 regulatory T cells in patients with chronic immune mediated thrombocytopenia purpura. Blood 2008;112:1325-1328
4. Olsson B, Anderson PO, Jemas M, et al. T cell mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003;9:1123-1124
5. Chow L, Aslam R, Speck ER, et al. A murine model of severe thrombocytopenia is induced by antibody and CD 8 T cell mediated responses that are differentially sensitive to therapy. Blood 2010;115:1247-1253
6. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. New Engl J Med 2007;357:2237-2247
7. Deka L, Gupta S, Gupta R, et al. Morphometric evaluation of megakaryocytes in bone marrow aspirates of immune mediated thrombocytopenic purpura. Platelets 2013;24:133-137
8. Muhury M, Mathai AM, Rai S, et al. Megakaryocytic alteration in thrombocytopenia: A bone marrow aspiration study. Indian J Pathology Microbiol 2009;52:490-494
9. Ballem PJ, Segal GM, Stratton JR, et al. Mechanism of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987;80:33-40
10. Chang M, Nokagawa PA, Williams SA, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 2003; 102:887-895
11. McMillan R, Wang L, Tomer A, et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004; 103:1364-1369
12. McMillan R. Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: Assays and epitopes. J Pediatr Hematol Oncol 2003;24:557-561
13. Lei Yang, Lin Wang, Chun-Hong Zhao, et al. Contributions of TRAIL-mediated megakaryocyte and platelet production in immune thrombocytopenia. Blood 2010;116:4307-4316
14. Li S, Wang L, Tomer A, et al. CD 8 T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. Br J Haematol 2007;139:605-611
15. Khudhayer A, Al-Khalissi, Kassim M, Sultan, Ahmad S. Mohammed. Chronic idiopathic thrombocytopenic purpura effects of certain variables on the response to treatment. Iraqi Postgraduate Med J 2012;11:45-49